1-10 of 10
Keywords: Parkinson’s disease
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Neuroendocrinology (2022) 112 (5): 427–445.
Published Online: 10 May 2022
... that PRL has on the central nervous system and addressed its contribution to neurodegeneration, but little is known about the mechanisms responsible for the effects of PRL on neurodegenerative disorders, especially on Alzheimer’s disease (AD) and Parkinson’s disease (PD). Summary: We review and summarize...
Journal Articles
Journal Articles
Journal Articles
Neuroendocrinology (1977) 23 (3): 129–132.
Published Online: 25 March 2008
.... MIF Dopaminergic-cholinergic balance Parkinson’s disease Planaria Neuroendocrinology 23: 129-132 (1977) Melanocyte-Stimulating Hormone Release-Inhibiting Factor (MIF): Lack of Dopaminergic and Anticholinergic Activity A. Carolei, V. Margotta and G. Palladini la Clinica delle Malattie Nervöse e...
Journal Articles
Journal Articles
Journal Articles
Neuroendocrinology (2004) 79 (6): 296–304.
Published Online: 20 August 2004
..., instructions or products referred to in the content or advertisements. Gonadal steroids Neuroprotection Parkinson’s disease Striatum Substantia nigra Methamphetamine Dopamine transporter We addressed a number of issues related to neuroprotection by E of the nigrostriatal dopaminergic system...
Journal Articles
Neuroendocrinology (2003) 78 (5): 244–252.
Published Online: 08 December 2003
... characterising three major neurodegenerative diseases: Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Special attention is focused on the contribution of disease transgenic models to elucidate such alterations. 4 07 2003 8 09 2003 8 12 2003 © 2003 S. Karger AG...
Journal Articles
Neuroendocrinology (2003) 77 (4): 223–231.
Published Online: 21 May 2003
...Andres D. Ramirez; Xingrong Liu; Frank S. Menniti Epidemiological data suggest that the steroid hormone 17β-estradiol plays an important role in protecting the brain from neurodegenerative processes, including that causing the loss of dopamine (DA) neurons in Parkinson’s disease. Determining...
Journal Articles
Neuroendocrinology (2003) 77 (4): 232–238.
Published Online: 21 May 2003
... a greater depletion to MPTP within female mice [ 15 ]). This gender difference in NSDA neurotoxicity and neurodegeneration may have direct clinical correlates as emergency room reported deaths to MA toxicity [ 16 ]and the incidence of the NSDA neurodegenerative condition, Parkinson’s disease [ 17, 18, 19...